Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-25-015682

Chief Financial Officer acquired 42,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-04 Grant or award : show line 1 in the form +42,000 89,218 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-04 Grant or award : show line 2 in the form Share Option (right to buy) +252,000 252,000 D
Loading xslF345X05/ownership.xml…